Twin Tree Management, LP Collegium Pharmaceutical, Inc Transaction History
Twin Tree Management, LP
- $51.8 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding COLL
# of Institutions
238Shares Held
35.9MCall Options Held
52.5KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$207 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.16MShares$113 Million2.15% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$94.2 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$80.1 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.58MShares$56.5 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.22B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...